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Evidence-based midwifery: 
finding, appraising and applying 
evidence in practice 
Lesley Page, Michael Corkett, Rona McCandlish 
In the first edition of this book Lesley Page (Page 
2000) described the experiences which began her 
journey of development as an evidence-based 
midwife saying: 
My own interest in what we now call 
evidence-based care started when I practised 
as a midwife in Canada, providing care for 
women and their families through the whole 
process of pregnancy and birth, for the first 
time in my experience as a midwife. As I got 
to know these women as individuals, I 
became increasingly aware of the impor-
tance of doing the right things for them as 
individuals. Inevitably, as we came to know 
each other through the course of pregnancy, 
the parents would start to ask why certain 
things were undertaken as a routine. Intui-
tively, I guessed that many of these routines, 
which were imposed in our large maternity 
hospital, were unfounded. It was only when 
I started to search for evidence, so that I 
could make an argument for abandoning 
some routines for the women in my care, that 
I began to realize just how senseless some of 
the routines were. For example, there was a 
very strict rule that there was to be abso-
lutely nothing to drink or eat in labour, yet 
many of the women I cared for wanted the 
freedom to eat and drink in labour. Thus, I 
started to investigate the evidence on the 
topic. This took me many hours. I contacted 
others who were undertaking research in the 
area in question, and used the library. Now, 
with a number of sources of synthesized evi-
dence, the search for evidence is easier in 
some areas. 
As reflected in Page's words evidence-based prac-
tice requires an awareness that care affects a con-
stellation of important outcomes, ranging from 
the physical and emotional, personal and family 
integrity, to the wider social and economic. 
Finding and understanding evidence to inform 
decisions and choices about care will mean con-
fronting uncertainty about what is best, or better, 
and dealing with frustration when the usefulness 
of evidence may not be straightforward. Although 
measurements of death or serious morbidity are 
conventionally used as key indicators of the effec-
tiveness and quality of care these do not encom-
pass the reality that pregnancy, birth and family 
life are more than physical 'events'. Measurement 
of the impact of maternity care is usually more 
complicated than simply 'counting' outcomes. 
This throws up the most challenging aspect of 
practising evidence-based midwifery: the need to 
weigh up the validity and applicability of evi-
dence about potential benefits and risks of certain 
choices and decisions whilst maintaining open 
and honest communication with women, families 
and colleagues. As a consequence evidence-based 
practice means that midwives often find them-
selves questioning long-standing routines in 
systems that are not easy to challenge. Effective 
questioning demands accumulating convincing 
evidence about what is likely to be effective care, 
developing effective skills to assemble and evalu-
ate evidence, and then using it to change practice 
for the better. Simply retrieving evidence is not 
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sufficient to practising evidence-based care; there 
is no point in collecting highest quality best evi-
dence if it is not used to improve practice and 
outcomes of care. Therefore the approach we 
describe in this chapter makes responding to the 
needs of women and their families the starting 
point for asking questions. 
There are two fundamental questions in 
evidence-based midwifery: 
1. Is what I intend to do likely to do more good 
than harm? 
2. Am I spending my time doing the right 
things? 
Every midwife can develop key skills to ask these 
questions, work through the answers and apply 
new learning, knowledge and insights effectively 
in her or his practice. The skills of lifelong learn-
ing and the ability to undertake independent 
enquiry are therefore crucial and this has implica-
tions both for the way in which midwives learn in 
basic education programmes and for continuing 
professional education. 
In this chapter we will discuss evaluating care 
and effective care, and briefly outline some of the 
influences to the development of evidence-based 
maternity care in the UK. 
EVALUATING AND ASSESSING THE 
EFFECTIVENESS OF CARE 
During the second half of the 20th century in the 
UK the drive to improve safety of birth through 
hospitalization and the use of technology and 
medical diagnosis was marked by imposition of 
treatments and care that were largely unevalu-
ated. This was demonstrated for example, by 
routine use of perineal shaving and enemas when 
women were admitted to the labour ward, and 
more recently in the increasing proportion of 
women who experience induction of labour and 
routine use of electronic fetal monitoring. Publica-
tion of the book Effective Care in Pregnancy and 
Childbirth (Chalmers et al 1989) brought about a 
greater awareness that the effects of maternity 
care should be rigorously evaluated. This seminal 
work was an important foundation for practi-
tioners and consumers accessing care to under-
stand different forms of evidence, and ways of 
judging the strength of that evidence, in deciding 
the probable effects of care. In addition, it synthe-
sized much of the relevant evidence for reference. 
From this, the Cochrane Collaboration and the 
Cochrane Library were developed (www.cochrane. 
org). 
The ability to evaluate and understand effects 
of care is crucial to the practice and provision of 
ethical healthcare. At its most benign not knowing 
the effects of an inert intervention mean its con-
tinued use with consequent misuse of limited 
healthcare resources. At worst, lack of evidence of 
effectiveness means that harmful practices are 
applied. There are clear instances of this in preg-
nancy and childbirth care when there has been 
unquestioned adoption of innovation which has 
led to avoidable tragedies. For example, Silverman 
(1980) describes the story of the 'epidemic' of neo-
natal retrolental fibroplasia which took hold in the 
1950s in the USA. This is a dramatic example of a 
well-intentioned treatment - in this case the 
administration of high concentrations of oxygen 
to premature babies - which had unknown and 
unsuspected adverse consequences. The oxygen 
regimens resulted in blindness in large numbers 
of the babies who had received the treatment. This 
unintended harm could have been minimized if 
practitioners who advocated the use of high-
concentration oxygen had been committed to 
asking questions about effectiveness (Box 10.1). 
This would have allowed them to evaluate whether 
the treatment they believed would work actually 
caused more good than harm. Instead, extremely 
vulnerable babies were exposed to a regimen of 
oxygen therapy which caused serious life-long 
morbidity. For lack of rigorous evaluation this 
form of care was continued for a decade longer 
than it should have been, and the concern it caused 
Effectiveness: ... a measure of the extent to 
which a specific intervention, procedure, 
regimen, or service, when deployed in the field in 
routine circumstances, does what it is intended 
to do for a specific population. 
Cochrane 1972 
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still acts as an impediment to carrying out research 
about different oxygen regimes for neonates 
(Silverman 1998). 
One of the difficulties about the term 'effective-
ness' is that it is understood differently by differ-
ent people. For example, imagine a policy of 
routine augmentation of labour is introduced for 
a trial period in your local labour ward to reduce 
the length of time women spend in labour care 
and that the effectiveness of the policy was meas-
ured after six months. The results of the evalua-
tion show a reduction in the time women spent in 
labour care and therefore it is proposed that the 
policy be adopted. However, the midwife respon-
sible for collating unit statistics points out that 
compared to the 6 month period previous to the 
introduction of the new policy, there has been a 
high rate of analgesia use and a high proportion 
of women have said they were dissatisfied with 
their experience of labour. This would suggest 
that measuring effectiveness using length of 
labour alone is inadequate and that adopting the 
policy would be unjustified as it could be associ-
ated with more harm than good. As this example 
demonstrates, judgements about the effects of 
care during pregnancy and childbirth, as in other 
areas, are neither value free nor situation free. 
Different observers see different problems and 
often reach different conclusions (Susser 1984, in 
Chalmers et al 1989) and it is vital to take these 
factors into account. 
EVIDENCE- CARE 
The movement towards 'evidence-based health-
care' (Gray 1997) has been important in helping 
healthcare professionals and others, including 
policy-makers and managers, understand that 
research is carried out so that the results it yields 
can be used. It challenges practitioners to consider 
whether they are simply practising in the ways 
they were first taught, or in response to being 
'told' by someone in authority, or perhaps from 
decisions based on personal opinion. Evidence-
based practice requires active searching for, and 
appraisal of, research evidence to inform deci-
sions about tests, treatments, patterns of practice, 
and policy. Although personal experience is an 
important basis to understanding what works and 
why, it is rarely wide enough to give objective 
answers about the effects of particular tests and 
treatments. 
Gray (1997, p. 213) describes evidence-based 
clinical practice as 'the judicious use of the best 
evidence available so that the clinician and the 
patient arrive at the best decision, taking into 
account the needs and values of the individual 
patient'. Evidence should be used to inform deci-
sions in a number of areas: policy, guidelines for 
practice, the appropriate organization of care, 
public health decisions (about the use of resources, 
for example), clinical decisions and information to 
help women's choice, health promotion and edu-
cation for parenting. 
Other chapters describe ways of using evidence 
in practice and described the sources of information 
used to inform decisions about care. These are: 
ll!l individual values or preferences; 
111 the clinical examination; 
llil research evidence; 
m the context of care. 
In that chapter, five steps for the use of evidence 
in practice are described: 
1. finding out what is important to the woman 
and her family; 
2. using information from the clinical 
examination; 
3. seeking and assessing evidence to inform 
decisions; 
4. talking it through; 
5. reflecting on outcomes, feelings and 
consequences. 
We now focus on the third step: finding and criti-
quing the evidence. 
Although evidence-based midwifery is about 
using rather than doing research, in common with 
primary research avoiding bias is funda-
mental when seeking, selecting and assessing 
evidence. 
The process of using evidence in practice 
includes: 
!ill framing clear and relevant questions that will 
lead to an effective search; 
1111 planning an efficient search to answer the 
question; 
111 assessing and weighing up the evidence. 
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FRAMIN QUESTIONS 
PRINCIPLES TO GOOD QUESTIONS 
A pre requisite to finding the right and best evi-
dence is the ability to convert a precise, yet possi-
bly vaguely expressed, need into an answerable, 
focused, structured question (Rosenberg & Donald 
1995, Straus et al 2005). Well-structured questions 
have four key components: 
1111 Population - in the case of midwifery, women. 
11!1 Intervention - cause, prognostic factor, treat-
ment. 
IIi Comparison - control or comparative interven-
tion. 
1111 Outcome - ways in which the intervention 
effect is measured. 
These are mnemonically referred to as PICO and 
provide a robust framework by which to execute 
a search. An additional component relating to 
study design can also be employed, and prove 
particularly helpful when improving the efficiency 
of a search (see Planning an efficient search). The 
most useful types of study design that may form 
part of a search include: 
1111 Systematic reviews -literature reviews focused 
on a single question which identify, appraise 
and synthesize all relevant high quality research 
evidence. 
1111 Meta-analyses - systematic reviews or over-
views which employ quantitative methods to 
summarize the results. 
111 Randomized controlled trials - patients are 
randomized into intervention and control 
groups, and followed up for outcomes. 
fill Cohort studies - identification of two groups 
(cohorts), one of which normally received expo-
sure to an intervention and one which did not 
and followed up for outcomes. 
Ill! Case-series -reports on a series of patients with 
outcomes. 
When including study design in a search it is 
important to remain aware of potential compro-
mises to quality. Always consider the quality of 
study design - the number of patients treated, or 
group size; the duration of the study; the objective 
measurement of outcomes; and, the elimination of 
bias. 
To assist the understanding and application of 
PICO to the midwifery setting Table 10.1 presents 
a modification of the work of Sackett et al (1997) 
and Straus et al (2005, p. 257-259). 
It is worth noting that in the maternity services 
the majority of women and families start off being 
healthy, and the aim should be to keep them that 
way. Because of this, the potential for doing harm 
is greater. One of the problems of maternity 
care in much of the industrialized world is the 
routine treatment of women as if they were a 
high-risk population with a high probability of 
adverse outcomes. In reality, the risk of an adverse 
outcome is lower than it has ever been. Therefore, 
many of the questions that midwives ask arise 
from the need to determine whether or not a 
woman is in a high-risk group; or, has the woman 
a higher chance than usual of an adverse 
outcome. 
EXERCISE 
Consider your own practice and think of a number 
of questions about the routines you undertake, 
then apply the PICO framework to each. 
For example, you may be looking after a woman 
who is experiencing leg cramps. The question 
might be: 
111 In a woman with a normal pregnancy who 
suffers severe leg cramps at night, is calcium 
supplementation likely to help; and are there 
any likely harmful side effects to this 
supplementation? 
Following the PICO framework the question can 
be illustrated as follows: 
1111 Population= women with a normal pregnancy, 
who suffer severe leg cramps at night. 
1111 Intervention = calcium supplementation. 
111 Comparison = an alternative intervention, for 
example exercise. 
1111 Outcome(s) =reduction of leg cramps; harmful 
side effects to supplementation. 
Now consider the following situation: 
Mrs Smith is approaching term. She has pre-
pared a birth plan indicating that she wishes to 
avoid intervention in labour. At her 39 weeks visit, 
the fundal height is 39 em, the fetus is active, her 
blood pressure is 120/85, and there is no protein 
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Table 10.1 Comparisons of good questions. (Adapted from Sackett et a! 1997, p. 27 with kind permission) 
1. Woman or problem 
Tips for building 
How would I best 
describe a group of 
women similar to mine? 
Examples 
In women in early 
pregnancy who are 
vomiting most of the 
day. 
In women without other 
complications 
In women of 26 years of 
age 
In nulliparous women 
without complications 




Which main intervention 
or complication or 'risk 
factor' am I considering? 
Acupressure 
Who are grand 
multiparous (greater 
than gravida 5) 
Who have an 
amniocentesis for the 
diagnosis of Down's 
syndrome 
Who have an elective 
prelabour caesarean 
section 
Who are over 40 years old 
in the urine. At this visit, Mrs Smith wonders 
whether it is enough to listen to the fetal heart 
regularly or whether she should think about 
having continuous electronic monitoring. 
Using what you have learnt about the PICO 
framework, and the examples provided in Table 
10.1, write a question to guide your search for 
evidence in the box opposite. (Box 10.2) 




What is the probability 
of adverse outcome? 
No Acupressure 
When compared with 
women who are less 
than gravida 5 
Who have not had 
amniocentesis for 
diagnosis of Down's 
syndrome 
Rather than allowing 
labour and vaginal birth 
Compared with women of 
under 40 years of age 
4. Outcome(s) 
What can I hope to 
accomplish? What else 
would be affected? 
Acupressure leads to a 
reduction of vomiting and 
the experience of nausea? 
Is there a greater 
probability of excessive 
bleeding, a need for blood 
transfusion, illness or 
death? 
What is the probability 
of miscarriage? 
What is the probability 
of Down's syndrome? 
What are the sensitivity 
and specificity of the 
test? 
What will the effect on 
perinatal mortality and 
morbidity, and maternal 
mortality and morbidity 
be? 
Is there a greater 
probability of adverse 
outcomes (e.g. perinatal 
mortality and higher 
intervention rates) as a 
result of age alone? 
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In women at term, with no problems during 
pregnancy, would continuous electronic fetal 
monitoring, rather than intermittently listening to 
the fetal heart, lead to lower mortality and mor-
bidity, and how would it affect intervention 
rates? 
OTHER TYPES OF QUESTION 
The questions considered so far have been con-
cerned with the effect of particular interventions 
on outcomes of care. While this represents an 
important part of clinical practice, a further large 
and important field for consideration encompasses 
decisions made concerning risk, or the probability 
of adverse outcomes. 
The most effective way to answer questions in 
this realm is to use systematic reviews and/or 
meta-analyses, which combine the results of a 
number of studies. This approach is particularly 
beneficial in those areas where a considerable 
Table 10.2 Resources for searching for evidence 
Resource Description 
National Comprehensive database of evidence-
Guideline based clinical practice 
Clearing house guidelines and related documents. 
National Organization responsible for 
Institute for providing UK guidance on promotion 
Health and of good health. Includes evidence-
Clinical based guidelines on maternal health. 
Excellence 
(NICE) 
Cochrane International organization providing 
Library regularly updated evidence-based 
systematic reviews. Includes 
systematic reviews on maternal 
health. 
National Aimed at providing UK clinicians with 
Electronic the best current know-how and 
Library for knowledge to support healthcare-
Health (NeLH) related decisions. Includes a 
dedicated midwifery section. 
MIDIRS digest High quality research papers from 
journals are selected by the midwife 
editor and abstracted. 
number of individual studies exist, and it would 
be beyond the available time of clinicians to rea<;i 
and appraise each. For example, when Olsen 
undertook his meta-analysis of the studies of 
home birth, he identified 65 separate studies that 
met his criteria (Olsen 1997). 
Midwives are fortunate to have available to 
them several evidence-based medicine resources 
that bypass the need to read and appraise numer-
ous individual studies. These include the National 
Guideline Clearing House, a repository of high-
quality international clinical guidelines; clinical 
guidelines produced in the UK by the National 
Institute for Health and Clinical Excellence (NICE), 
in particular those concerned with women's and 
children's health; the Cochrane Library, an exten-
sive collection of rigorously appraised systematic 
reviews; and MIDIRS, a specialist midwifery 
information service. Further details on these 
resources can be found in Table 10.2. 
Access Availability 
www.guidelines.gov Free of charge 
www.nice.org.uk Free of charge 
www.cochrane.org Free of charge 
www.nelh.nhs.uk Free of charge 
Hardcopy digest Subscription 
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Standard and individual searches 
are available that scan the content 
of 500 English language journals, 
including midwifery, obstetrics and 
gynaecology, paediatrics, neonatal 
and key general medical and 
consumer titles. 
Evidence-based healthcare journal 
providing concise and easy to read 
summaries of the latest systematic 
reviews and meta-analyses. Includes 
maternal health section. 
Summarizes current knowledge and 
uncertainty about the prevention 
and treatment of clinical conditions, 
based on thorough searches and 
appraisal of the best available 
evidence. Includes section on 
maternal health. 
The National Library of Medicine 
(US) online database of 
approximately 15 million biomedical 
and pharmaceutical citations, 
searched via natural language 
and/or controlled vocabulary. 
The National Library of Medicine 
service, providing access to 
Medline back to the 1950s. Includes 
links to many full text articles 
and related resources. 
A powerful database providing access 
to several million biomedical 
citations, via natural language 
and/or controlled vocabulary 
searches. 
Database regarded as the authoritative 
source of information for the 
professional literature of nursing, 




www.ebandolier.com Free of charge 
www.clinicalevidence.com Free of charge 
Subscription 
www.ncbi.nlm.nih.gov/entrez Free of charge 
Subscription 
Subscription 
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PLANNING AN EFFICIENT SEARCH 
Having devised a structured question it is possi-
ble to begin the search for evidence. Searching for 
evidence has been described as an essential clini-
cal skill that demands to be efficient (Sackett et al 
1997). With the unmanageable volume of informa-
tion available to health professionals well 
documented, the need for efficiency is crucial 
(Greenhalgh 1997). 
When planning a search it is important to con-
sider the kind of evidence needed, and where it is 
most likely to be found. Research may be pub-
lished or unpublished, can be found in non-peer-
reviewed or peer-reviewed journals, and vary 
widely in quality (see Principles of good ques-
tions). Also, it is important to know how much 
time can be realistically spent, not only searching 
for but also appraising the evidence retrieved. 
Midwives may elect to use resources that bypass 
the need to execute searches themselves. Beyond 
those previously described, there are also useful 
journals that provide structured abstracts as a 
means to alert clinicians to important advances, 
and up-to-date books, which may prove particu-
larly useful for understanding physiology. 
Many clinicians, however, are likely to execute 
searches by themselves using one or more bio-
medical database. The best well known are 
Medline, Embase, and the Cumulative Index to 
Nursing and Allied Health Literature, commonly 
known as CINAHL. 
It is important to appreciate that confining a 
search to only one database risks the exclusion of 
either a majority, or large minority, of the available 
evidence. Research has demonstrated that using 
only one database to identify evidence is inade-
quate (Suarez-Almazor et al 2000). The overlap 
between Medline and Embase, in terms of jour-
nals indexed, is about 40% (Smith et all992), and 
studies have demonstrated that using both data-
bases markedly improves the coverage of litera-
ture (Biarez et al1991, Odaka et al1992). 
A considered search strategy is important when 
using resources such as Medline and Embase, 
each consisting of several million records. While 
Greenhalgh (1997) says that most people can learn 
to carry out a basic search of either database inside 
an hour, it is worthwhile investing some time in 
preparation and design of a search strategy before 
the searching begins in earnest. Straus et al (2005) 
provide a diagram of the steps for executing a 
pragmatic search for evidence (Fig. 10.1). 
When using databases to search for evidence 
problems may be experienced. A search strategy 
may be highly sensitive, which will result in too 
much evidence, or a search may prove too specific, 
which will considerably lessen the return of 
evidence. 
To counter such difficulties preparation is the 
key. Depending upon the results of a search it may 
prove necessary to narrow or widen the date range 
being searched; limit or expand the population 
sub-groups; determine the quality of evidence 
being sought; or limit evidence to that published 
in English. Most important of all, understand 
what it is that is actually being sought. Has a 
focused, well-structured question been asked? 
Has a population, comparison, intervention, 
outcome, and, if necessary, study design, been 
identified? Are the correct resources being em-
ployed that will most likely hold the evidence 
sought, and best utilize the available time? 
The resources listed in Table 10.2 are examples, 
together with descriptions, that will greatly assist 
the search for evidence. 
BASIC MEDLINE AND EMBASE SEARCH 
A basic search for evidence using Medline or 

















Figure. 10.1 General search strategy 











Evidence-based midwifery: finding, appraising and applying evidence in practice 211 
II! using natural language (text words) to seek par-
ticular authors and institutions where research 
is carried out, and words in the title and/ or 
abstract; 
l!iil using Medical Subject Headings (MeSHt or the 
controlled vocabulary of the databases, that 
constitute powerful theasuri. 
An individual's ability to search for evidence will 
be greatly enhanced if they acquire an under-
standing of the following skills, adapted from 
Sackett et al (1997, p.73): 
l!iil the use of both natural language and MeSH; 
l!iil the identification of MeSH using the thesauri; 
l!iil the ability to identify synonyms directly related 
to MeSH and incorporate them into a search; 
111 the appropriate use of search field tags (e.g. 
abstract = .ab; author = .au; paper title word = 
.ti; textword = .tw); 
111 the ability to use search field tags as limiters (e.g. 
publication type = .pt; publication year= .py); 
l!iil the appropriate truncation of natural language 
and use of wildcards to replace characters within 
words; 
!l!l the ability to employ adjacency commands so 
linking words or phrases to each other; 
1111 combining natural language, including search 
field tags, and MeSH by using Boolean operators 
(AND, OR, NOT) to expand and limit a 
search. 
Medical librarians and information specialists 
have historically been regarded as experts in the 
field of searching for evidence; however, today 
there are many opportunities, via dedicated train-
ing courses and/or self-tuition, for health profes-
sionals to learn how to conduct effective and 
efficient searches. 
ASSESSING AND INTERPRETING 
THE CE 
Once you consider that you have found the appro-
priate information to answer your question, it is 
necessary to assess the quality of the information 
to ensure that it is right for your purposes and that 
it provides valid evidence to answer your ques-
tion. There are several accessible books that detail 
structured approaches to assessing research 
reports (see especially Greenhalgh 1997, Gray 1997, 
Sackett et al1997, Straus et al2005). 
An essential first step in assessing the evidence 
is to discard poor-quality or irrelevant reports. 
Greenhalgh (1997) emphasizes the need to 'trash' 
papers and suggests that 'some purists would say 
99% of published articles belong in the bin' (p. 34). 
She makes a strong argument that the quality of 
a paper is best assessed through the methods 
section and that the article should be 'trashed' on 
methods alone before looking at the results. She 
suggests three preliminary and basic questions as 
a way of getting an orientation to the paper are: 
1. Why was the study done, what were the hypoth-
eses, and what were the authors testing? 
2. What type of study was carried out? 
3. Was this research appropriate to the broad field 
of research studied? 
Sackett et al (1997) propose the following ques-
tions to assess evidence: 
filii Is it true (valid)? 
m Are the valid results important? 
111 Does it apply to the woman/women in my 
care? 
VALIDITY 
When reviewing evidence from a study both 
internal and external validity (Box 10.3) of the 
results need to be considered. Internal validity is 
concerned with whether selection of groups and 
the way comparisons were carried out between 
the study's groups were sufficiently robust so that 
any reported difference is likely to be attributable 
to the effect being measured. External validity is 
concerned with the extent to which research 
findings can be generalized to people who are 
Validity: The degree to which the inference 
drawn from a study, especially generalizations 
extending beyond the study sample, are 
warranted when account is taken of the study 
methods, the representativeness of the study 
sample, and the nature of the population from 
which it is drawn. 
Last 1995 
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similar to the participants but who did not take 
part in the study. A fundamental point when 
assessing evidence, and the validity of a study, is 
to question whether the methodology used is 
appropriate to the question posed (Box 10.4). 
IMPORTANCE 
Assessment of importance is related to the 
111 size and potential benefits of the effects meas-
ured in a study; 
ill! probability of outcomes occurring over time; 
Most research studies are concerned with one or 
more of the following: 
IIi Therapy - testing the efficacy of drug 
treatments, surgical procedures, alternative 
methods of service delivery, or other interven-
tions. Preferred study design is randomized 
controlled trial. 
11!11 Diagnosis - demonstrating whether a new 
diagnostic test is valid (can we trust it?) and 
reliable (would we get the same results every 
time?). Preferred study design is cross 
sectional survey ... in which both the new 
test and the gold standard test are performed 
e Screening - demonstrating the value of tests 
that can be applied to large populations and 
that pick up disease at a presymptomatic 
stage. Preferred study design is cross sec-
tional survey. 
m Prognosis-determining what is likely to 
happen to someone whose disease is picked 
up at an early stage. Preferred study design is 
longitudinal cohort study. 
11!1 Causation-determining whether a putative 
harmful agent, such as environmental 
pollution, is related to the development of 
illness. Preferred study design is cohort or 
case-control study, depending on how rare 
the disease is ... but case reports ... may 
also provide crucial information. 
Reproduced from Greenhalgh T 1997 How to read a 
paper. With kind permission from BMJ Books, BMJ 
Publishing Group. 
ll1l strength of association between the outcomes 
(either harmful or good) and interventions; 
IIi increased probability of particular outcomes in 
different groups; 
IIi precision of the estimates of effect. 
Established methods are applied to numerical 
data reported in a study which are used to assess 
the importance of the results. For example, Straus 
et al (2005) describe the method to calculate how 
many people need to be treated to avoid an adverse 
outcome (number needed to treat; NNT) or to 
harm one person (number needed to harm; NNH). 
Measures of importance, strength of association 
and precision include relative risks, absolute risk 
reduction, Number needed to treat (NNT), and 
number needed to harm (NNH), odds, odds ratios 
and confidence intervals. The explanations of 
the terms by Straus et al (1998, pp. 141-145, 2005 
pp.281-284) are outlined below: 
1111 Odds - a ratio of non-events to events. If the 
event rate for a disease is 0.1 (10%), its non-
event rate is 0.9 and therefore its odds are 9 : 1. 
Note this is not the same as the inverse of event 
rate. 
1111 Odds ratio (OR) - is the odds of having the 
target disorder in the experimental group rela-
tive to the odds in favour of having the target 
disorder in the control group or the odds of 
being exposed in subjects with the target dis-
order divided by the odds in favour of being 
exposed in control subjects (without the target 
disorder). 
fill Risk ratio (RR) -is the ratio of risk in the treated 
group (EER) to the risk in the control group 
(CER) RR = ERR/CER. 
1111 Relative risk reduction (RRR) -the proportional 
reduction in rates of bad outcomes between 
experimental and control groups. 
Iiiii Absolute risk reduction (ARR) - the absolute 
arithmetic difference in rates of bad outcomes 
between experimental and control groups. 
1111 Number needed to treat (NNT) - the number 
of patients who need to be treated to achieve 
one additional favourable outcome, calculated 
as 1/ ARR and accompanied by a 95% confidence 
interval. If the ARR is 25% 1/25% = 4. 
1111 Number Needed to Harm - the number of 
patients who need to be treated to achieve one 
additional unfavourable outcome, calculated as 
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1/ ARR and accompanied by a 95% confidence 
interval. If the ARR is 25% 1/25% = 4. 
1!11 Confidence interval (CI) - expresses the range 
within which we would expect the true value 
of a statistical measure to fall. Few studies can 
be carried out amongst all of the people who 
would be eligible to experience the care or 
therapy being assessed. Therefore for a particu-
lar research study a sample is selected compris-
ing people who it is hoped will be representative 
of the relevant population. This means that the 
results of that study should be considered as an 
estimate of measured effect(s), and need to 
be placed in the context of the likely upper 
and lower value of the effect should the same 
study be repeated with different representative 
samples. Cis are usually accompanied by a 
percentage value, which shows the level of 
confidence that we have that true value lies 
within this range. For example, for an NNT of 
10 with a 95% CI of 5-15, we would have 95% 
confidence that the true value of NNT values 
was between 5-15. 
APPLICATION TO WOMEN AND 
FAMILIES IN YOUR CARE 
Questions of application are concerned with the 
similarity between the women and families in 
your care and those in reported research and 
should take into account their individual prefer-
ences and values. 
APPRAISING EVIDENCE FOR VALIDITY 
AND IM 
The assessment of the validity of particular studies 
will depend on the type of evidence used. Sackett 





111 systematic reviews 
!ill decision analysis 
111 qualitative research. 
The following is based on the work of Straus et al 
(1998, 2005), using their categories for structured 
steps for appraisal. We have summarized many of 
the suggestions from three sources: Sackett et al 
(1997), Straus et al (1998, 2005) and the handbook 
from the 1998 Oxford workshop on teaching 
evidence-based medicine (University of Oxford 
1998). 
DIAGNOSIS 
One of the most rapidly changing fields of mater-
nity care lies in diagnosis and screening, particu-
larly during the antenatal period. Midwives 
should be able to appraise current evidence and 
convey the accuracy of results to the women and 
families in their care. This area is perhaps one of 
the most complex of practice (see Chapter 11), and 
an understanding of key terms, such as sensitivity 
and specificity (see Box 10.5), is crucial not only to 
interpreting evidence, but also to interpreting test 
results and understanding their predictive value 
in practice. 
Sensitivity: the proportion of people with the 
target disorder who have a positive test. It is 
used to assist in assessing and selecting a 
diagnostic test/sign/symptom. 
SnNout: when a sign/test/symptom has a high 
sensitivity, a negative result rules out the 
diagnosis. 
Specificity: the proportion of people without the 
target disorder who have a negative test. It is 
used to assist in assessing and selecting a 
diagnostic test/sign/symptom. 
SpPin: when a sign/symptom has a high 
specificity, a positive result rules in the 
diagnosis. 
Positive predictive value: the proportion of 
people with a positive test who have the 
target disorder. 
Negative predictive value: the proportion of 
people with a negative test who are free of 
the target disorder. 
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Assessing validity 
Straus et al (2005, pp 72-73) suggest using the fol-
lowing questions to appraise a paper or systematic 
review on diagnosis: 
1. Was there an independent, blind comparison 
with a reference 'gold' standard of diagnosis? 
2. Was the diagnostic test evaluated in an appro-
priate spectrum of patients (like those in whom 
it would be used in practice)? 
3. Was the reference standard applied regardless 
of the diagnostic test result? 
Was there an independent, blind comparison with 
a reference 'gold' standard of diagnosis? 
Two criteria should have been met in order to 
answer this question in the affirmative. First, the 
women or babies in the study should have under-
gone both the diagnostic test in question (for 
example, nuchal fold scanning for Down syn-
drome) and the reference (or 'gold') standard of 
testing (e.g. amniocentesis for Down syndrome). 
Second, the person interpreting the tests of one 
should not know the results of the other, other-
wise, consciously or subconsciously, the inter-
pretation might be biased. 
It is sometimes difficult to provide reference 
standards, but a definition of what is 'normal' has in 
some way to be agreed. Straus et al (2005, p. 69) use 
the diagnostic definition of normal alongside other 
definitions of normal, shown below in Box 10.6. 
Was the diagnostic test evaluated in an 
appropriate spectrum of patients (like those in 
whom it would be used in practice)? 
For example, if you are asking a question about 
the use of nuchal fold testing in all age groups of 
women, you would want it to be tested in a popu-
lation of all age groups of women. 
Was the reference standard applied regardless of 
the diagnostic test result? 
Sackett says that when patients have a negative 
diagnostic test result, investigators are tempted to 
forego applying the reference standard, and when 
the latter is invasive (for example, an amniocente-
sis), it may be considered inappropriate to do so. 
Sackett suggests that if the report fails one or more 
of these criteria, you may wish to keep searching 
sources for further evidence. 
1. Gaussian: the mean± standard deviations. 
Assumes a normal distribution and means 
that all 'abnormalities' have the same 
frequency. 
2. Percentile: within the range, say, of 5-950fo. 
Has the same basic defect as the Gaussian 
definition. 
3. Culturally desirable: preferred by society. 
Confuses the role of medicine. 
4. Risk factor: carrying no additional risk of 
disease. Labels the outliers, who may not be 
helped. 
5. Diagnostic: range of results beyond which 
target disorders become highly probable- the 
focus of this discussion. 
6. Therapeutic: range of results beyond which 
the treatment does more good than harm. 
Means you have to keep up with advances in 
therapy. 
Is this evidence about a diagnostic 
test important? 
Once you have decided on the validity of the 
report or reports, it is appropriate to ask whether 
the evidence is important. Just because some-
thing is published does not mean that it is 
important! 
Sackett et al (1997, p. 118) describe 'a modern 
way of thinking about diagnosis that takes into 
account both components of evidence-based med-
icine; your individual clinical expertise and the 
best external evidence'. This includes assessment 
of the prior assessment of possibilities before car-
rying out the test (prior or pretest probabilities) 
and the ability of the test to distinguish patients 
with and without the target disorder (sensitivity 
and specificity, and likelihood ratios). (See also 
Straus et al 2005, p. 82). The definitions of these 
terms are shown below. 
Diagnostic tests: key terms 
Sensitivity: the proportion of people with the 
target disorder who have a positive test. It 
is used to assist in assessing and selecting 
a diagnostic test/sign/symptom. 
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SnNout: when a sign/test/symptom has a 
high sensitivity, a negative result rules out 
the diagnosis. 
Specificity: the proportion of people without 
the target disorder who have a negative 
test. It is used to assist in assessing 
and selecting a diagnostic test/sign/ 
symptom. 
SpPin: when a sign/symptom has a high 
specificity, a positive result rules in the 
diagnosis. 
Positive predictive value: the proportion of 
people with a positive test who have the 
target disorder. 
Negative predictive value: the proportion of 
people with a negative test who are free of 
the target disorder. 
Likelihood ratio: the likelihood that a given 
test result would be expected in a patient 
with the target disorder compared with 
the likelihood that the same result would 
be expected in a patient without the target 
disorder. 
Straus et al 2005, pp 282-283 
Once you have determined validity and impor-
tance, the following questions help to determine 
whether or not you can apply this valid, important 
evidence to women and families in your care 
(Straus et al 2005, pp79-86): 
111 Is the diagnostic test available, affordable, accu-
rate, and precise in your setting? 
111 Can you generate a clinically sensible estimate 
of your patient's pre-test probability (from prac-
tice data, from personal experience, from the 
report itself, or from clinical speculation)? 
11111 Will the resulting post-test probabilities affect 
your management and help your patient? 
(Could it move you across a test-treatment 
threshold? Would your patient be a willing 
partner in carrying it out?) 




Is this question about prognosis valid? 
In general medicine the issue of prognosis:'How 
long have I got until I develop the condition in 
question' maps onto risk estimation in maternity 
care. An example question might be 'What is the 
increased probability of postpartum haemorrhage 
when a woman is gravida 6' (see Chapter 17). In 
assessing evidence related to prognosis for valid-
ity, we need to ask (adapted from Straus et al2005, 
pp101-102): 
1. Was a defined, representative sample of pa-
tients (women/fetuses/babies) assembled at a 
common (usually early) point in the course of 
their pregnancy? 
2. Was follow up of participants sufficiently long 
and complete? 
3. Were objective outcome criteria applied in a 
blind fashion? 
4. If subgroups with different prognoses are 
identified 
Iii! Was there adjustment for important 
prognostic factors? 
1111 Was there validation in an independent 
group of test set patients (women/fetuses/ 
babies)? 
The following example is designed to help think 
through whether the conclusions of a study about 
using maternal age as a prognostic factor for oper-
ative delivery were valid, and structured abstract 
(Rosenthal & Paterson-Brown 1998, p. 1064): 
Objective To determine whether increasing 
maternal age increases the risk of opera-
tive delivery and to investigate whether 
such a trend is due to fetal or maternal 
factors. 
Design Analysis of prospectively collected 
data on a maternity unit data base. 
Population 6410 nulliparous women with 
singleton cephalic pregnancies delivering 
at term (37-42 weeks of gestation), nul-
liparous women with singleton cephalic 
pregnancies delivering at term between 1 
January 1992 and 31 December 1995. 
Setting The study was undertaken in a 
teaching hospital. There was a population 
of 6410. The results showed a positive 
highly significant association between 
increasing maternal age and obstetric 
intervention. 
Main outcome measures Mode of delivery, rates 
of prelabour caesarean section, induction 
of labour and epidural usage. 
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Results There were a positive, highly 
significant association between increasing 
maternal age and obstetric intervention 
prelabour (P < 0.001) and emergency (P < 
0.001) caesarean section, instrumental 
vaginal delivery (spontaneous labour P 
<0.001; induced labour P = 0.001), induc-
tion of labour (P < 0.001). Epidural usage 
in induced labour and the incidence of 
small for gestational age newborns did not 
increase with increasing maternal age (P == 
0.68 and P = 0.50, respectively). 
Conclusions This study demonstrates that 
increasing age is associated with an incre-
mental increase in obstetric intervention. 
Previous studies have demonstrated a 
significant effect in women older than 35 
years of age, but these data show changes on 
a continuum from teenage years. This 
finding may reflect a progressive, age-related 
deterioration in myometrial function. 
(Reproduced with kind permission from 
Blackwell Science Ltd.) 
We can look at this paper against the framework 
of two of Sackett et al's (1997) questions: 
Was a defined, representative sample of patients 
assembled at a common (usually early} point in 
the course of their disease? 
This was a retrospective review of what is 
described as 'prospectively' gathered data which 
had been routinely collected. Information that 
might help to explain and define some of the 
measures (for example, the definition and diagno-
sis of fetal distress) was missing from the data 
collection. There are important gaps in the 
reported data, for example about the early preg-
nancy of women who participated in the study 
and about diagnosis of fetal distress. There are a 
number of indications in the report that the popu-
lation studied may be different from the normal 
population of women giving birth. For example, 
the intervention rate in the hospital in which the 
study took place was described as higher than 
average and the women who were part of the 
study were described as having a higher than 
average age, and a larger proportion of 'career 
women'. This limits the confidence with which we 
might generalize the findings as the women in 
this study may not be representative of women in 
other populations. Length of follow-up was appro-
priate in a study that was concerned only with 
intervention rates. 
Were objective criteria applied in a blind fashion? 
Some of the criteria, for example operative delivery, 
are objective; others, such as failure to progress and 
fetal distress, are more subjective measures. There 
is no clear definition of criteria for the diagnosis of 
fetal distress and failure to progress (both of these 
being prone to bias in clinical interpretation). There 
is no mention of blinding for interpretation or for 
analysis. There was also no adjustment for prog-
nostic factors. It is also possible that higher anxiety 
experienced by health professionals attending older 
women may be a factor in increasing the rate of 
interventions in older women, and as this study has 
not tested this important hypothesis. In studies 
examining the effect of maternal age on outcome 
that are adequately controlled for factors which 
may confound the outcomes, no significant differ-
ences are found (Harker & Thorpe 1992). There is 
no control or reanalysis for confounding factors, 
such as raised blood pressure, in this study. 
The higher incidence of epidural analgesia in 
spontaneous labour may well have been an inde-
pendent factor in increasing the intervention rate. 
Moreover, there is no mention of the fetal monitor-
ing rate, which is likely to have been higher in this 
group of women, and which is in itself associated 
with a higher rate of intervention and a falsely 
high rate of diagnosis of fetal distress. A number 
of factors, including mobility and position in 
labour, may have affected the outcome; but none 
of these are described in the report. In addition, 
the lack of clear definition of failure to progress 
and fetal distress, which may be highly subjective 
assessments, is a fundamental flaw in this study. 
Attendant anxiety may well have affected the 
judgements made, in itself leading to a higher rate 
of intervention. 
In assessing this study it is important to be 
aware of the idea that labelling particular women 
as being at increasing risk of intervention in labour 
becomes a self-fulfilling prophecy. It is quite likely 
that attendant anxiety or perception is likely to 
affectthe outcome oflabour (and this has not been 
refuted by this study). There is a danger of the 
outcomes of such studies being confounded, that 
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is, being affected by other factors than the one 
under study, in this case increasing age. Examples 
of potential confounders in this group of women 
would be the pre-existence of medical problems 
in subgroups of older women, or the tendency of 
health professionals to treat older women as being 
at higher risk, leading to a higher rate of continu-
ous electronic fetal monitoring, which in itself 
produces a higher intervention rate. Unfortu-
nately, the authors of this study did not heed the 
warnings of one of the papers they referenced 
(Harker & Thorpe 1992) and did not control for 
such confounding factors. 
Is this evidence about prognosis important? 
In relation to importance, two questions are 
relevant: 
1. How probable are the outcomes over time? 
2. How precise are the prognostic estimates? 
Given the flaws of the study, its validity is in doubt 
and therefore it would not be appropriate to deter-
mine the importance. 
Two further questions then follow. 
Were the study patients similar to your own, 
and will this evidence make a clinically 
important impact on your conclusions about 
what to offer or tell your patients? 
In this case, the flaws which have been identified 
in response to the questions above lead to the 
conclusion that the results are not valid. Therefore 
it would not be appropriate to change practice on 
the basis of the evidence from this study. Perhaps 
the only change in practice that should be consid-
ered would be to be more aware that bias caused 
by regarding older women as inherently at risk of 
adverse outcomes can itself increase the interven-
tion rate. 
HARM 
Is this evidence about harm valid? 
Straus et al (2005, p. 179) propose the following 
questions to assess the validity of studies to evalu-
ate the possibility of harm: 
1. Were there clearly defined groups of patients, 
similar in all-important ways other than expo-
sure to the treatment or other cause? 
2. Were treatment exposures and clinical out-
comes measured the same ways in both groups 
(e.g. was the assessment of outcomes either 
objective (for example, death) or blinded to 
exposure)? 
3. Was the follow up of study patients complete 
and long enough? 
4. Do the results satisfy some 'diagnostic tests for 
causation'? 
1!111 Is it clear that the exposure preceded the 
onset of the outcome? 
111 Is there a dose response gradient? 
11 Is there positive evidence from a challenge-
rechallenge study? 
11 Is the association consistent from study to 
study? 
l'lll Does the association make biological 
sense? 
This is a question of whether or not a treatment 
caused the harmful outcome experienced and thus, 
as Sackett et al (1997) tell us, 'benefits from what 
has been learned from classical epidemiology'. 
There are four possible designs for a study of the 
harmful effects of treatments. These are the rand-
omized controlled trial, the cohort study, the case 
control study, or reports of one or two patients 
who have suffered from something that is unique 
and rare. Table 10.3 is a summary of the advan-
tages and disadvantages of these approaches, as 
described by Sackett et al 1997. 
Using evidence to inform practice 
Let us look at the above questions with regard to 
a study to examine the effect of neonatal exposure 
to vitamin K on the risk of childhood cancer 
(Klebanoff et al 1993). The relationship between 
vitamin K and cancer was examined in a nested 
case control study that used data from the Col-
laborative Perinatal Project, a multicentre, pro-
spective study of pregnancy, delivery and 
childhood that took place in the USA. Among 
54,795 children born between 1959 and 1966, 48 
cases of cancer were diagnosed after the first day 
of life and before the eighth birthday. Each 
case child was matched with randomly selected 
controls whose last study visit occurred at or 
after the age when the case child's cancer was 
diagnosed. 
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Table 10.3 Advantages and disadvantages of different kinds of harm study. (From Sackett et al 1997, with 
kind permission) 
Type of study Advantages Disadvantages 
Randomized controlled trial Randomization would make groups similar for all 
other features that would cause harm 
For rare events, very large trials 
would be needed (one per 
thousand would need 3000 
patients in order to be 950/o 
certain of seeing at least one 
adverse reaction) 
Cohort study Next most powerful design The groups of patients (cohorts) 
may not be identical in every 
respect. Other things apart from 
the treatment being evaluated 
such as severity of illness may 
affect outcome. Same problem of 
size applies 
Case control studies For rare or late complications of treatment, 
need to rely on studies in which those who 
already have the disease are assembled and 
compared with a group who do not have 
the disease 
The problem of confounding (of 
prognosis with exposure) is 
worse with case control studies 
because it may be impossible 
to measure confounders in a 
case even if they are known 
Case reports and case series Reports of one or two patients who developed a 
complication while under treatment (e.g. 
phocomelia in children born to women who 
took thalidomide) 
May be enough but usually point 
to the need for further studies 
Were there clearly defined groups of patients, 
similar in all-important ways other than exposure 
to the treatment or other cause? 
The rarity of the disease in this case makes a ran-
domized controlled trial impractical for answer-
ing the question of harm and makes the case 
control study the only practical design. Attempts 
were made to adjust for factors that might be asso-
ciated with the development of childhood cancer 
(for example, race, sex, birth weight, maternal age, 
exposure to X-rays during pregnancy, and breast-
feeding). Nevertheless, we cannot be confident 
that the groups were similar in every respect. 
Were treatment exposures and clinical outcomes 
measured in the same ways in both groups (e.g. 
was the assessment of outcomes either objective, 
for example death, or blinded to exposure)? 
"he report states that 'two investigators who were 
blinded to the child's vitamin K status examined 
all records of children with cancer. Definite cases 
of cancer were required to have a histologically 
proved diagnosis of cancer, a clinical course 
including treatment consistent with the diagnosis 
or both' (Klebanoff et al1993, p. 905). 
Was the follow-up study of patients complete and 
long enough? There is no account of loss to 
follow-up, but the authors state that, afterwards, 
loss to follow-up was accounted for by life table 
methods. The study followed children up to 8 
years of age. 
Do the results satisfy some diagnostic tests 
for causation? 
111 Is it clear that the exposure preceded the onset of the 
outcome? It is as clear as can be that the 
exposure preceded the outcome. There was 
Evidence-based midwifery: finding, appraising and applying evidence in practice 219 
reclassification for children with cancer before 
their first birthday, and therefore with the pos-
sibility that the cancer started in pregnancy. 
1111 Is there a dose-response gradient? No dose-
response gradient was available, but babies 
whose mothers were given vitamin K in the 
intrapartum period were excluded. All babies 
received the intramuscular vitamin K. In addi-
tion, there was an analysis of effect according 
to the brand of vitamin K used. There was then 
reanalysis to exclude the children in whom the 
administration of vitamin K was uncertain. 
Because this was part of a larger study not aimed 
primarily at the evaluation of the effect of vitamin 
K, it is particularly important to be sure that 
vitamin K was actually administered when it was 
recorded and that all vitamin K was recorded 
when given. Recording in this situation was prob-
ably more careful because this was part of a 
research study with special documentation that 
was checked for completeness. In addition, there 
was recording by an observer in the delivery room 
of any drugs administered. 
m Is there positive evidence from a challenge-rechal-
lenge study? The challenge-rechallenge ques-
tion (seeingwhathappens if a drug is withdrawn 
or re-administered) is not appropriate to this 
drug. 
1111 Is the result consistent from study to study? The 
answer to this is no. The authors comment on 
two earlier studies including an evaluation of 
the effect of the administration of oral vitamin 
K that found twice the expected risk of cancer 
during childhood with the administration of 
vitamin K. 
!Ill Does the association make biological sense? There 
is no biological link made explicit in this stud~ 
but the fact that the incidence of childhood 
cancer has not increased with the frequent 
administration of vitamin K at birth increases 
confidence in the findings of the study. 
Are the valid results from this harm 
study important? 
Importance is evaluated against an estimation of the 
strength of the association between receiving the 
treatment and suffering the adverse effect. Strength 
here means the risk or odds of the adverse effect, 
with, as opposed to without, exposure to the treat-
ment; the higher the risk or odds, the greater the 
strength and the more one should be impressed 
with it. Different tactics are used for estimating the 
strength of the association for different research 
methods. This is illustated in Table 10.4. 
Using the data presented in the paper on 
vitamin K (Klebanoff et al 1993), this calculation 
is as shown in Table 10.5 and shows that, in this 
case, there is no association between Vitamin K 
and cancer. 
Can the study results be extrapolated to 
your patient? 
Given the situation in the USA, with such different 
demographic characteristics, direct extrapolation 
is not appropriate. One factor that is pointed out 
by the authors as being different is that the vehicle 
Table 10.4 Calculating the strength of an association between a treatment and subsequent adverse out-
comes. (Reproduced from Sackett et al 1997, with kind permission) 
Adverse outcome Totals 
Present Absent 
(Case) (Control) 
Yes a b a+b 
Exposed to (Cohort) 
the No c d c+d 
treatment (Cohort) 
Totals a+c b+d a+b+c+d 
In a randomized trial or cohort study: relative risk= RR = [a{(a+b)]/[c/(c+d)] In a case-control study: relative odds= RO =ad/be 
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Table 10.5 Calculating the strength of an 




Yes 33 171 
vitamin a b 
Exposed K 
to the 
treatment No vitamin c d 
K 15 69 
Controls 
33.69 2277 = 0 89 
15.171 2565 . 
of administration of the vitamin K differs between 
the USA and the UK. 
THERAPY 
If one wants to find out whether a treatment is 
likely to be of benefit, the most appropriate meth-
odology to answer the question is a randomized 
controlled trial. There are so many factors that 
might influence the outcome of treatment that the 
only good way to control for possible sources of 
bias is to allocate people randomly to different 
treatment conditions. 
In this section, we will look at assessing the 
evidence from a single study. If several studies are 
available, the investigator should first look for a 
systematic review and use that as a starting 
point. 
Before going on to assess the results of a study, 
one must first ask the following questions. 
Are the results of this single study valid? 
The key questions to answer, following Straus 
et al (2005, p. 117)are: 
1. Was the assignment of patients to treatments 
randomized? 
2. And was the randomization list concealed? 
3. Were patients and clinicians kept blind to which 
treatment was being received? 
4. Aside from the experimental treatment, were 
the groups treated equally? 
5. Were the groups similar at the start of the trial? 
Studies of treatment (or therapy) compare out-
comes in groups receiving the treatment with out-
comes in groups either not receiving treatment or 
receiving an alternative treatment. It is essential 
that, at the outset, the groups being compared are 
as alike as possible. The only way to avoid bias 
when assigning people to groups is to make the 
assignments random. This does not guarantee 
that the groups will be identical, but it does ensure 
that any differences are more likely to be caused 
by chance alone. 
For example, imagine that you are looking for 
a treatment for pregnancy-induced nausea and 
have heard that acupuncture worked. You decide 
to test this out by carrying out a randomized con-
trolled trial to compare women who have been 
allocated acupuncture with those who have not. 
If you are testing the effectiveness of acupuncture 
compared to another form of care you would want 
to make sure that your groups consisted of a 
mixture of women with different severities of the 
condition, different lifestyles and a different toler-
ance of the symptoms: Uneven distribution of 
these factors between groups may confound your 
results by providing an alternative explanation for 
any result that you see, for example by exaggerat-
ing, counteracting or even cancelling out the 
effects of the therapy. If the random allocation is 
concealed from clinicians, they will be unaware 
of the treatment that the patient is receiving and 
will not be able to distort the effect, either con-
sciously or unconsciously. 
It would be important to set up a system so that 
you can ensure that you can account for all the 
women who were randomized, right through to 
the end of follow-up. This means that you would 
make every effort to account for women who were 
randomized but who dropped out from follow-up 
It is possible to analyse and report the results of a 
trial even when there has been 'loss' to follow-up 
by assigning those participants the 'worst' value 
of the outcome of interest. In the example of acu-
puncture for nausea in pregnancy, all the partici-
pants who did not contribute information to 
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follow-up might be considered to have experi-
enced no improvement in nausea. However, as a 
rule of thumb, this approach is not useful if more 
than 20% of participants are lost to follow-up. 
The correct method for a randomized con-
trolled trial is to analyse results by 'intention-to-
treat'. This means that the data are analysed 
according to the groups to which the participants 
were assigned when they were first randomized 
in the trial, and not according to their experience 
of care after assignment. For example, in a rand-
omized controlled trial of home birth to assess the 
effect of home birth on intervention rates a number 
of women are likely to be transferred to hospital 
to give birth because of failure to progress or some 
other problem. If intention-to-treat analysis was 
not used to analyse the results, and outcomes are 
evaluated according to the location of birth, there 
would be a falsely low intervention rate in the 
home birth group. An intention to treat analysis 
provides an estimate of the effects of interventions 
in practice, by taking into account the reality that 
care and therapies do not always happen exactly 
as defined or prescribed. 
In real practice it is often impossible to conceal 
(blind) the nature of allocated treatment/care for 
participants and clinicians. However it may be 
possible to have the outcomes being evaluated 
assessed by people who are unaware of what the 
original allocation was. 
Are the results of this single preventive or 
therapeutic trial important? 
Straus et al (2005, pp 126-130) propose calculating 
the number needed to treat (NNT), as a way of 
concealing how relevant and important the results 
of a study would be to the people you are working 
with. If a valid study found, for example, that you 
needed to treat four people to have one respond 
to the treatment, this gives a clear indication of 
how many people you would need to treat and the 
chance of a response in the population of people 
you are caring for. The view of thes~ numb.ers 
differs for the midwife and the ch1ldbeanng 
woman. A midwife may want to know that for 
every four women she treats, one will respond to 
treatment. For the childbearing woman, the most 
useful presentation of these figures is that she has 
a 1 in 4 chance of responding to therapy. 
SYSTEMATIC REVIEW AND 
META-ANALYSIS 
Although it is important to critically appraise the 
results of individual research studies, there are 
instances when it is possible to identify topics for 
which major work has already been achieved to 
synthesize and review evidence from several 
studies. In maternity care the Cochrane Library 
(www.cochrane org) is probably the most well-
known important resource of reliable reviews of 
evidence. Increasingly other agencies are publish-
ing the results of commissioned reviews to inform 
care (for example NICE May 2005, HTA 2005). 
Differences between systematic review and meta-
analysis are outlined below. 
A systematic review is a review that includes 
explicit and detailed description of why and how 
it was conducted so that it should be possible to 
replicate it (Jahad 1998). In should clearly state a 
research question and methods used to assemble 
data, explicitly taking into account issues such as 
bias, confounding and chance in interpretation of 
findings. Ideally its authors should seek to bring 
together research from all relevant evidence 
sources. It should clearly present the results of 
individual studies but should not combine 
results unless it is appropriate statistically to do 
so and issues such as bias and heterogeneity 
between studies have been satisfactorily dealt 
with. 
Meta-analysis is a method of combining 
statistically the results of independent research 
studies, which are sufficiently similar, to generate 
a single estimate of effect for a particular 
treatment or therapy. The benefit to using this 
method is that it can increase the precision of 
the estimate of effect, thereby reducing uncer-
tainty about what the range of the estimate is 
likely to be. 
Straus et al (2005, p. 148) propose the following 
questions to test the validity of a systematic 
review: 
1. Is it an overview of RCTs of the treatment you 
are interested in? 
2. Does it include a methods section that 
describes: 
a. Finding and including all the relevant 
trials? 
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b. Assessing their individual validity? 
3. Were the results consistent from study to study? 
The first question asks whether you are sure that 
the treatment is the same as the one you are inter-
ested in and the others whether all the studies 
were carried out at the same, most powerful level 
of evidence. 
For example, if a randomized controlled trial of 
vitamin K prophylaxis were available and you 
wanted to know whether oral vitamin K were 
effective, you would want to ask whether it was 
oral or IM vitamin K that had been tested. 
Some overviews combine randomized and non-
randomized studies. It is wrong to combine results 
from these different research methods and we 
would advise that you should not use results from 
such reviews to change practice. 
DOES IT INCLUDE A METHODS SECTION 
THAT DESCRIBES (A) FINDING AND 
INCLUDING ALL THE RELEVANT 
TRIALS, AND (B) ASSESSING THEIR 
INDIVIDUAL VALIDITY? 
The most important point to remember is that 
carrying out a systematic review is just like carry-
ing out research. In other words, it uses the same 
approach as research to avoid bias and should be 
reported like research. As in the assessment of 
research, look carefully at the methods section. 
This should include a description of how the 
studies were identified which were included and 
excluded, and why. Straus et al (2005, p. 149) 
describe the importance of having sought unpub-
lished results and of hand-searching for reports. 
The methods section should also say how the 
validity of the study was judged. 
Were the results consistent from study 
to study? 
Although we should not expect all trials to show 
exactly the same degree of effectiveness, it is reas-
suring if the results are not widely different. 
Are the results of this systematic 
review important? 
Deciding whether or not a treatment is important 
depends on the size and potential benefits of the 
effects of the treatment you are interested in. 
Do these results apply to your patient? 
m Is your patient so different from those in the 
overview that its results can't help you? 
1111 How great would the potential benefit of 
therapy actually be for your individual patient 
(e.g. what is the NNT/NNH)? 
1111 Do your patients and you have a clear assess-
ment of their values and preferences? 
1111 Are they met by this regimen and its con-
sequences? 
It is crucial to remember that systematic reviews 
and meta-analyses are no better than the studies 
they combine therefore applying critical appraisal 
methods to both is necessary. 
ASSESSING QUALITATIVE RESEARCH 
!J~~~!ii!W#treW.\!:IW.tt\'~W\l2fl~~~B~ill 
Qualitative research is important to all profession-
als working in the maternity services, but it is 
perhaps most important to midwives. Midwives 
hold the potential for strong and intimate 
relationships with childbearing women and their 
families as well as the potential for changing 
the experience of care and of pregnancy and 
birth. 
Greenhalgh (1997, p. 151) describes clearly the 
limitations of quantitative research and the impor-
tance of qualitative research in 'seeking a deeper 
truth'. She quotes the aim of qualitative research 
as being 'to study things in their natural setting, 
attempting to make sense of, or interpret, phe-
nomena in terms of the meanings that people 
bring to them', and that researchers use a 'holistic 
perspective which preserves the complexity of 
human behaviour (Denzin & Lincoln 1994)'. The 
contribution of social science and anthropology in 
researching maternity care is immense and 
provides a mine of information regarding the 
perspectives of childbearing women using the 
maternity services and their experiences, to inform 
midwives who want to understand better and 
improve care. 
Greenhalgh (1997, see pp 155-61) suggests the 
following questions for assessing qualitative 
research. She is clear about the limits of such a 
checklist, and it should be used with caution. 
Qualitative research is by its very nature non-
standard; and this list of questions is taken from 
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Greenhalgh to provide a structure. However, it is 
advisable to read Greenhalgh's chapter in full and 
to refer to the list of further reading at the end of 
that chapter. 
DID THE PAPER DESCRIBE AN 
IMPORTANT CLINICAL PROBLEM 
EXAMINED THROUGH A CLEARLY 
FORMU QUESTION? 
As with quantitative research, the topic area needs 
to be clearly defined. The process is iterative so the 
question may emerge more clearly at the end of 
the project, although it should still be clearly 
stated. 
WAS A QUALITATIVE APPROACH 
APPROPRIATE? 
It is most appropriate when the objective is to 
explore, interpret or obtain a deeper understand-
ing of a particular issue. 
HOW WERE THE SETTING AND 
SUBJECTS SELECTED? 
1$ [ ~00\Ml W &\&iiiil!i&WJ&.W#IM\i\IW hiil'!\lttliii!Mi&l!%1\**~'tmmmwmpmJ!W.Wlt!ll!1ffi"t~ 
The study should go beyond a convenience sample 
to a theoretical sample. Instead of taking an 
average view, the aim is to achieve an in-depth 
understanding of particular individuals, for 
example, a group of Somali women receiving 
maternity care in west London. 
WHAT WAS THE RESEARCHER'S VIEW, 
AND HAS THIS BEEN TAKEN INTO 
ACCOUNT? 
It is important to recognize that there is no way 
of controlling for observer bias in qualitative 
research. It is thus important that the in-
vestigator's personal perspective is fully 
explained. 
WHAT METHODS DID THE RESEARCHER 
USE FOR COLLECTING DATA, AND ARE 
THESE DESCRIBED IN ENOUGH DETAIL? 
& & 
The methods section is likely to be lengthy and 
discursive. You should ask the question. 'Have I 
been given enough information on methods?' 
There are no hard and fast rules. 
WHAT METHODS DID THE RESEARCHER 
USE TO ANALYSE THE DATA, AND WHAT 
QUALITY CONTROL MEASURES WERE 
IMPLEMENTED? 
The researcher must have found a systematic way 
of analysing the data. A number of methods are 
available, which include content analysis. A good 
paper will describe a method of quality control; 
in other words, it will not depend on just the inter-
pretation of one person. 
ARE THE RESULTS CREDIBLE? 
The results should be independently and objec-
tively verifiable. Are they sensible and believable, 
and do they matter in practice? 
WHAT CONCLUSIONS WERE DRAWN, 
AND WERE THEY JUSTIFIED BY THE 
RESULTS? 
Greenhalgh suggests using these three 
questions: 
11111 How well does this analysis explain why people 
behave in the way they do? 
111 How comprehensive would this explanation be 
to a thoughtful participant in the setting? 
111 How well does the explanation cohere with 
what we already know? (Mays & Pope 1996). 
CONCLUSION 
It is easy to feel overwhelmed by the never-ending 
deluge of information about developments and 
changes in practice and care. The world-wide web 
has given everyone with access the possibility of 
finding almost infinite sources of information and 
sources of evidence that healthcare practitioners 
use are increasingly available to the women and 
families using maternity services. This should 
lead to invigorating information-sharing and into 
exciting and innovative realms of practice. 
However it must not mean abdication of respon-
sibility by midwives for retrieving and appraising 
evidence, and thinking through its implications to 
midwifery practice and to the wellbeing and 
health of women and families. In this chapter we 
outlined structured and systematic approaches to 
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use to find, assess and evaluate evidence. Just as 
you would apply a structure when undertaking a 
clinical examination, this framework will help 
you to make sure that you have covered key issues 
and think through whether there is anything 
important that has been missed out. 
It is important not to be intimidated by the 
mystique and sense of elitism that sometimes sur-
rounds research in midwifery. Do not be afraid to 
make judgements about whether or not research 
findings make sense on a basic level. Your every-
day experience and the knowledge you gain from 
practice give you an important basis for judging 
whether or not things simply make sense. 
Although you should be aware of the limitations 
of personal knowledge in making generalizations, 
your general sense about whether or not a piece 
of research is 'somehow just not right' can be an 
invaluable tool to cut through the information 
'jungle'. 
We believe that asking questions that arise 
from practice and being able to find, evaluate, and 
implement the findings of research are crucial to 
ensuring that midwifery care is likely to be 
beneficial and to avoid harm. However, we often 
find that there is no strong evidence to help answer 
questions arising from practice. In that case, the 
challenge is to be honest about the sources we use 
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